Formycon AG (XTER:FYB) Accounts Payable : €16.95 Mil (As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Formycon AG Accounts Payable?

Formycon AG's Accounts Payable for the quarter that ended in Jun. 2024 was €16.95 Mil.

Formycon AG's quarterly Accounts Payable declined from Jun. 2023 (€19.72 Mil) to Dec. 2023 (€16.32 Mil) but then increased from Dec. 2023 (€16.32 Mil) to Jun. 2024 (€16.95 Mil).

Formycon AG's annual Accounts Payable increased from Dec. 2021 (€7.61 Mil) to Dec. 2022 (€11.32 Mil) and increased from Dec. 2022 (€11.32 Mil) to Dec. 2023 (€16.32 Mil).

Formycon AG Accounts Payable Historical Data

The historical data trend for Formycon AG's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG Accounts Payable Chart

Formycon AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

2.21

4.48

7.61

11.32

16.32

Formycon AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable	Get a 7-Day Free Trial															9.64	11.32	19.72	16.32	16.95

Formycon AG Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Formycon AG Accounts Payable Related Terms

Thank you for viewing the detailed overview of Formycon AG's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Formycon AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

0W4N:UK

Address

Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.formycon.com

Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID-19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.

Executives

Dr. Nicola Mikulcik	Board of Directors
Dr. Stefan Glombitza	Board of Directors
Dr. Carsten Brockmeyer	Board of Directors
Dr. Nicolas Combé	Board of Directors

Formycon AG Headlines

No Headlines